ABT - Company ID 0000001800
The table below shows ABBOTT LABORATORIES's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.05B | $5.10B | $6.80B | $7.51B | $6.95B | $6.53B |
| Short-term investments | $246.00M | $499.00M | $492.00M | $222.00M | $331.00M | $312.00M |
| Receivables | $9.03B | $8.60B | $8.21B | $8.14B | $7.97B | $7.33B |
| Inventory | $7.34B | $7.32B | $6.99B | $6.71B | $6.95B | $6.64B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $23.50B |
| $24.52B |
| $25.51B |
| $24.84B |
| $24.47B |
| $23.15B |
| Property, plant & equipment | $12.88B | $12.81B | $12.38B | $11.50B | $11.39B | $10.93B |
| Goodwill | $32.64B | $35.24B | $35.22B | $23.97B | $23.95B | $23.36B |
| Total assets | $108.25B | $109.22B | $110.43B | $84.18B | $84.00B | $81.45B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $16.15B | $17.81B | $18.38B | $14.58B | $13.44B | $13.00B |
| Long-term debt | $29.45B | $29.60B | $29.64B | $11.60B | $12.93B | $12.74B |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | $49.64B | $49.79B | $49.96B | $49.10B | $48.47B | $47.72B |
| Total equity | $51.03B | $51.11B | $52.06B | $50.95B | $50.56B | $48.81B |